Recent Finacing
Recent Raise
AbilityPharma, a Barcelona-based biopharmaceutical company, develops oral autophagy‑inducing anticancer ABTL0812, currently in a multicenter, double‑blind Phase 2b trial in pancreatic cancer and other Phase 2 studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Ability Pharmaceuticals.
